Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196Pharmaceuticals
CN¥22.31−3.04%As of Oct 29vs prior close
- Market cap
- $7.1B
- P/E (TTM)
- 17.3×
- P/E (FY1)
- 20.3×
- From 52W high
- −23.60%
- EPS (LTM)
- CN¥1.29
- Revenue (LTM)
- CN¥42.7B
- Net margin
- 8.23%
Nomior Score
29
Steady ProfileBottom 15% of the scored universe
Growth43
Quality46
Value47
Momentum5
Resilience54
Growth
−1.77%revenue a year over 3 fiscal years
YE22 CN¥44BLTM CN¥42.7B
Connections
Revenue to profitYE25
8% of revenue became net profit, up 1 pt on a year.